Daily Stock Analysis, SLP, Simulations Plus Inc, priceseries

Simulations Plus Inc. Daily Stock Analysis
Stock Information
Open
40.82
Close
41.61
High
42.35
Low
40.79
Previous Close
40.94
Daily Price Gain
0.67
YTD High
52.54
YTD High Date
Jan 7, 2022
YTD Low
35.18
YTD Low Date
Feb 24, 2022
YTD Price Change
-8.17
YTD Gain
-16.41%
52 Week High
73.39
52 Week High Date
Mar 16, 2021
52 Week Low
35.18
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-20.73
52 Week Gain
-33.25%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 20. 2017
9.91
Apr 4. 2017
10.48
11 Trading Days
5.67%
Link
LONG
Jul 18. 2017
13.27
Jul 27. 2017
14.15
7 Trading Days
6.59%
Link
LONG
Apr 5. 2018
14.82
Apr 27. 2018
16.73
16 Trading Days
12.91%
Link
LONG
May 2. 2018
16.97
May 21. 2018
18.42
13 Trading Days
8.55%
Link
LONG
Feb 8. 2019
19.22
Feb 28. 2019
20.26
13 Trading Days
5.41%
Link
LONG
Jul 10. 2019
28.98
Aug 2. 2019
36.23
17 Trading Days
25.00%
Link
LONG
Jan 9. 2020
31.38
Jan 23. 2020
33.30
9 Trading Days
6.12%
Link
LONG
Apr 8. 2020
34.08
Apr 30. 2020
38.65
15 Trading Days
13.41%
Link
LONG
Sep 23. 2020
64.76
Oct 2. 2020
68.64
7 Trading Days
5.99%
Link
LONG
Dec 14. 2020
59.07
Jan 12. 2021
74.53
19 Trading Days
26.18%
Link
LONG
Oct 22. 2021
39.37
Nov 22. 2021
55.69
21 Trading Days
41.45%
Link
Company Information
Stock Symbol
SLP
Exchange
NasdaqCM
Company URL
http://www.simulations-plus.com
Company Phone
661-723-7723
CEO
Walter S. Woltosz
Headquarters
California
Business Address
42505 10TH STREET WEST, LANCASTER, CA 93534-7059
Sector
Equity
Industry Category
Computer Software & Services
Industry Group
Business Software & Services
CIK
0001023459
About

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. Its services include consulting services, modeling and analysis or simulation, pharcometric data assembly, and training and workshops. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Description

Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. The company distributes its products and services worldwide. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.